Alpine Global Management, LLC Aclaris Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.01 - $1.36 $179,688 - $241,956
177,909 New
177,909 $195,000
Q1 2022

May 13, 2022
SELL
$9.74 - $17.92 $199,942 - $367,861
-20,528 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $251,878 - $379,562
20,528 New
20,528 $298,000
Q1 2021

May 13, 2021
SELL
$5.86 - $27.73 $130,871 - $619,294
-22,333 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$2.65 - $7.61 $59,182 - $169,954
22,333 New
22,333 $144,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email